These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 22517884)

  • 1. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
    Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC
    Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.
    Wu H; Lee J; Vincent LG; Wang Q; Gu M; Lan F; Churko JM; Sallam KI; Matsa E; Sharma A; Gold JD; Engler AJ; Xiang YK; Bers DM; Wu JC
    Cell Stem Cell; 2015 Jul; 17(1):89-100. PubMed ID: 26095046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients.
    Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A
    Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs.
    Stroik DR; Ceholski DK; Bidwell PA; Mleczko J; Thanel PF; Kamdar F; Autry JM; Cornea RL; Thomas DD
    J Mol Cell Cardiol; 2020 Jan; 138():59-65. PubMed ID: 31751570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.
    Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.
    Wyles SP; Hrstka SC; Reyes S; Terzic A; Olson TM; Nelson TJ
    Clin Transl Sci; 2016 Jun; 9(3):158-67. PubMed ID: 27105042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
    Perea-Gil I; Seeger T; Bruyneel AAN; Termglinchan V; Monte E; Lim EW; Vadgama N; Furihata T; Gavidia AA; Arthur Ataam J; Bharucha N; Martinez-Amador N; Ameen M; Nair P; Serrano R; Kaur B; Feyen DAM; Diecke S; Snyder MP; Metallo CM; Mercola M; Karakikes I
    Eur Heart J; 2022 Sep; 43(36):3477-3489. PubMed ID: 35728000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.
    Wyles SP; Li X; Hrstka SC; Reyes S; Oommen S; Beraldi R; Edwards J; Terzic A; Olson TM; Nelson TJ
    Hum Mol Genet; 2016 Jan; 25(2):254-65. PubMed ID: 26604136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cytosolic calcium buffering contributes to a cellular arrhythmogenic substrate in iPSC-cardiomyocytes from patients with dilated cardiomyopathy.
    Jung P; Seibertz F; Fakuade FE; Ignatyeva N; Sampathkumar S; Ritter M; Li H; Mason FE; Ebert A; Voigt N
    Basic Res Cardiol; 2022 May; 117(1):5. PubMed ID: 35499658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.
    Schick R; Mekies LN; Shemer Y; Eisen B; Hallas T; Ben Jehuda R; Ben-Ari M; Szantai A; Willi L; Shulman R; Gramlich M; Pane LS; My I; Freimark D; Murgia M; Santamaria G; Gherghiceanu M; Arad M; Moretti A; Binah O
    PLoS One; 2018; 13(10):e0205719. PubMed ID: 30332462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
    Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
    J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs.
    Chen G; Li S; Karakikes I; Ren L; Chow MZ; Chopra A; Keung W; Yan B; Chan CW; Costa KD; Kong CW; Hajjar RJ; Chen CS; Li RA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):193-202. PubMed ID: 25504561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional defects in hiPSCs-derived cardiomyocytes from patients with a PLEKHM2-mutation associated with dilated cardiomyopathy and left ventricular non-compaction.
    Korover N; Etzion S; Cherniak A; Rabinski T; Levitas A; Etzion Y; Ofir R; Parvari R; Cohen S
    Biol Res; 2023 Jun; 56(1):34. PubMed ID: 37349842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An abnormal TRPV4-related cytosolic Ca
    Lu J; Lee YK; Ran X; Lai WH; Li RA; Keung W; Tse K; Tse HF; Yao X
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2964-2972. PubMed ID: 28754452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy.
    Nakano SJ; Walker JS; Walker LA; Li X; Du Y; Miyamoto SD; Sucharov CC; Garcia AM; Mitchell MB; Ambardekar AV; Stauffer BL
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1221-H1230. PubMed ID: 31625780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Badone B; Ronchi C; Lodola F; Knaust AE; Hansen A; Eschenhagen T; Zaza A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.